STOCK TITAN
  1. Home
  2. News
  3. ZY

Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022. The company’s management will host a conference call beginning at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss its results, business developments and outlook.

A webcast of the conference call can be accessed at https://investors.zymergen.com/.

About Zymergen

Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world.

Investor Contact
Carrie Mendivil
investors@zymergen.com

Media Contact
Mike Dulin
mdulin@zymergen.com


Stock ZY logo
Zymergen Inc

NASDAQ:ZY

ZY Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

ZY Latest News

Oct 19, 2022
Ginkgo Bioworks Completes Acquisition of Zymergen
Jul 25, 2022
Ginkgo to Acquire Zymergen
Jul 14, 2022
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
Jun 28, 2022
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
May 26, 2022
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

ZY Stock Data

Other Chemical and Fertilizer Mineral Mining
Mining, Quarrying, and Oil and Gas Extraction
Link
United States
Emeryville

About ZY

Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to create, develop and manufacture breakthrough products and materials across a broad range of industries.